The Patient-focused ‘Paradigm Shift’ That Could ‘Revolutionise’ Clinical Trials

Melanie Anderson, Principal Scientist at MSD, on how the pandemic has made scientists rethink clinical trials.

Read More


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *